43
Participants
Start Date
January 31, 2005
Primary Completion Date
October 31, 2005
Study Completion Date
October 31, 2005
Pemetrexed
Pemetrexed 500 mg/m2 IV q 3 weeks
Helen F. Graham Cancer Center, Newark
Indiana University Cancer Center, Indianapolis
Community Regional Cancer Center, Indianapolis
Elkhart Clinic, Elkhart
Center for Cancer Care at Goshen Health System, Goshen
Northern Indiana Cancer Research Consortium, South Bend
Northern Indiana Oncology Associates, South Bend
Fort Wayne Oncology & Hematology, Inc, Fort Wayne
Center for Cancer Care, Inc., P.C., New Albany
Medical Consultants, P.C., Muncie
Oncology Hematology Associates of SW Indiana, Evansville
AP&S Clinic, Terre Haute
Arnett Cancer Care, Lafayette
Medical & Surgical Specialists, LLC, Galesburg
Siteman Cancer Center, St Louis
Methodist Cancer Center, Omaha
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Walther Cancer Institute
OTHER
Hoosier Cancer Research Network
OTHER